U.S. flag

An official website of the United States government

NM_000451.3:c.(?_-692)_(-433+1_-432-1)del AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Feb 14, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003155751.1

Allele description [Variation Report for NM_000451.3:c.(?_-692)_(-433+1_-432-1)del]

NM_000451.3:c.(?_-692)_(-433+1_-432-1)del

Gene:
SHOX:short stature homeobox [Gene - OMIM - OMIM - HGNC]
Variant type:
Deletion
Preferred name:
NM_000451.3:c.(?_-692)_(-433+1_-432-1)del
HGVS:
NM_000451.3:c.(?_-692)_(-433+1_-432-1)del

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003844691Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Feb 14, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Evaluation of SHOX defects in the era of next-generation sequencing.

Funari MFA, de Barros JS, Santana LS, Lerario AM, Freire BL, Homma TK, Vasques GA, Mendonca BB, Nishi MY, Jorge AAL.

Clin Genet. 2019 Sep;96(3):261-265. doi: 10.1111/cge.13587. Epub 2019 Jul 4.

PubMed [citation]
PMID:
31219618

SHOX gene and conserved noncoding element deletions/duplications in Colombian patients with idiopathic short stature.

Sandoval GT, Jaimes GC, Barrios MC, Cespedes C, Velasco HM.

Mol Genet Genomic Med. 2014 Mar;2(2):95-102. doi: 10.1002/mgg3.39. Epub 2013 Oct 14.

PubMed [citation]
PMID:
24689071
PMCID:
PMC3960050
See all PubMed Citations (3)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV003844691.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

Variant summary: SHOX c.(?_-692)_(-433+1_-432-1)del is located in the untranscribed region upstream of the SHOX gene region and involves exon 1. A presumed nomenclature of c.(?_-692)_(-433+1_-432-1)del has been designated for the purposes of this classification. The SHOX gene is located in a pseudoautosomal region of the X and Y chromosomes, and a similar variant allele encompassing the deletion of exon 1 was found at a frequency of 0.00065 in 21646 control chromosomes, predominantly at a frequency of 0.0054 within the East Asian subpopulation in the gnomAD Structural Variants database. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 11-fold of the estimated maximal expected allele frequency for a pathogenic variant in SHOX causing Short Stature phenotype (0.0005), suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. However, deletion of exon 1 has been reported in individuals affected with Short Stature and was indicated to segregate with disease in at least one family (Shima_2016, Funari_2019). Since the expressivity of SHOX deficiency is highly variable (see e.g. PMID: 21325865), these data indicate that the variant may be associated with Short Stature, but it is unclear if it could contribute to more severe phenotypes. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic for Short Stature phenotype.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 1, 2023